Physical symptoms like fatigue or unexplained aches and pains
Metformin is commonly used as first-line therapy unless contraindicated or poorly tolerated, but the addition of glucose-lowering therapies with different mechanisms of action is usually needed to provide adequate glycemic control [1,2,3], with the choice of agent being dependent on multiple factors, such as cost and the presence of comorbidities [1]
Statistical analysis Changes in continuous outcomes from baseline, including hemoglobin A1c and body weight, were evaluated using paired statistical methods
Injection site reactions are recognised adverse effects and can include redness, swelling, and localised itching at the site where the subcutaneous injection is administered
He shifted the blame to pharmacy benefit managers (PBMs), explaining that Ozempic and Wegovy would likely no longer be offered by PBMs if they had a lower list price